Who Paid My Doc
Glycate
Drug Peptic Ulcer Disease
NDC 80056-160-10
General payments
$629,316
Research payments
$0
Through program year 2025, $629,316 in general payments and $0 in research payments were reported against Glycate (Peptic Ulcer Disease).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $365,029 | 5,243 |
| 2024 | General | $108,875 | 2,920 |
| 2023 | General | $155,411 | 2,347 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 72 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 31 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
10,510 generalEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.